Vincent Sibaud

24PUBLICATIONS
60CO-AUTHORS
GlycoconjugatesAllergyMedicinal and biomolecular chemistry not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 08, 2026
Optimized management of enfortumab vedotin-related dermatological toxicity.

|Jun 08, 2026
Immune checkpoint inhibitor-induced eosinophilic fasciitis: A pharmacovigilance and EADV Task force study.

|Jun 06, 2026
Tralokinumab for immune checkpoint-induced pruritic dermatoses.

|Feb 11, 2026
Dermatologic adverse events associated with amivantamab: A multicentre study.

Vasiliki Nikolaou, Ander Mayor, Vincent Sibaud

|Oct 30, 2025
Prevention and management of cutaneous immune-related adverse events: EADV Task Force statement.

Davide Fattore, Zoe Apalla, Azael Freites-Martinez

|Oct 16, 2025
Dupilumab for immune checkpoint inhibitors-induced pruritic dermatoses: A retrospective, multicentric study.

Damien Giacchero, Vincent Sibaud, Emilie Gerard

Pageof 4

Frequent Collaborators

12 joint publications

Zoe Apalla

10 joint publications

Azael Freites-Martinez

8 joint publications

Davide Fattore

7 joint publications

Michela Valeria Rita Starace